Atomo DiagnosticsASX:AT1 Gross Margin % is 37.06% as of Dec. 2025, which is 1% above its 10-year median of 36.86. The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Atomo Diagnostics ranks worse than 67.2% on this metric.
The historical rank and industry rank for Atomo Diagnostics's Gross Margin % or its related term are showing as below:
ASX:AT1'
s Gross Margin % Range Over the Past 10 Years
Min: -10.25 Med: 36.86 Max: 50.91
Current: 40.75
During the past 6 years, the highestGross Margin % of Atomo Diagnostics was 50.91%. The lowest was -10.25%. And the median was 36.86%.
ASX:AT1's Gross Margin % is ranked worse than 67.2% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs ASX:AT1: 40.75
Atomo Diagnostics had a gross margin of 37.06% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Atomo Diagnostics was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Atomo Diagnostics had a gross margin of 37.06% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Atomo Diagnostics Gross Margin % Related Terms
Atomo Diagnostics Gross Margin % Historical Data
* Premium members only.
The historical data trend for Atomo Diagnostics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:AT1 vs ABT, SYK, MDT: Gross Margin % Comparison
For the Medical Devices subindustry, Atomo Diagnostics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atomo Diagnostics Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Atomo Diagnostics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Atomo Diagnostics (ASX:AT1) has a Gross Margin % of 37.06% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Atomo Diagnostics and its competitors. This is near median its historical median of 36.86. According to the industry distribution chart, Atomo Diagnostics ranks #541 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 67.2%.
Is Atomo Diagnostics' Gross Margin % too high?
Atomo Diagnostics' current Gross Margin % of 37.06% is near median its 10-year median of 36.86. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Atomo Diagnostics' value of 37.06% is 28.8% below this industry median. Based on the distribution chart, Atomo Diagnostics ranks #541 out of 805 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Atomo Diagnostics' Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Atomo Diagnostics ranks #541 out of 805 companies for Gross Margin %. This places Atomo Diagnostics in the lower half of its industry. The industry median Gross Margin % is 52.07. Atomo Diagnostics' value of 37.06% is 28.8% below this benchmark. While the company's 10-year median is 36.86 vs. the industry median of 52.07, Atomo Diagnostics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atomo Diagnostics's current Gross Margin % of 37.06% is 28.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Atomo Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atomo Diagnostics's current Gross Margin % is 37.06%, which is near median its own 10-year median of 36.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 15% below its estimated fair value. The current Gross Margin % is 37.06%, which is near median its 10-year median of 36.86 and 28.8% below the Medical Devices & Instruments industry median of 52.07. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current Gross Margin % is 37.06% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AT1 has been successfully added to your 